Guus van Dongen

PROF.DR., (Principal Investigator)

1982 …2024

Research activity per year

Network

Iris Miedema

Person: Academic

Riekeld Scheper

Person: Academic

Henk Dekker

Person: Academic, Administrative

Esther Hulleman

Person: Academic

Paul Lips

Person: Academic

M. Stigter-van Walsum

  • VU Medisch Centrum

External person

Mariska Verlaan

  • VU University Medical Center
  • VU Medical Center

External person

Marijke Stigter-Van Walsum

  • VU Medisch Centrum
  • VU University Medical Hospital
  • Vrije Universiteit Amsterdam

External person

Frank B. Van Gog

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Iris Verel

  • VU Medisch Centrum
  • Massachusetts General Hospital
  • VU University Medical Hospital

External person

M.S. Walsum

  • VU Medisch Centrum
  • Departments of Otolaryngology/Head and Neck Surgery

External person

Marijke Stigtervan Walsum

  • VU University Medical Center
  • VU Medisch Centrum

External person

Maxime Schreurs

  • VU Medical Center

External person

P Lambin

  • Maastricht University
  • KU Leuven

External person

Martijn Gerretsen

  • VU Medisch Centrum

External person

Esther J. M. Kooijman

  • VU University Medical Center
  • VU Medisch Centrum
  • VU Medical Center

External person

Elisabeth G. E. de Vries

  • University Medical Center Groningen
  • University of Groningen

External person

Adrienne H. Brouwers

  • University Medical Center Groningen
  • University Medical Center Groningen, Centre for Revalidation (Beatrix Children's Hospital)
  • Afdeling Nucleaire Geneeskunde en Moleculaire beeldvorming
  • University of Groningen
  • Department of Obstetrics and Gynaecology

External person

Maarten B. Vrouenraets

  • University of Groningen
  • VU University Medical Hospital
  • VU Medisch Centrum

External person

Esther Kooijman

  • VU University Medical Center

External person

Marjolijn N. Lub-de Hooge

  • University of Groningen
  • Afdeling Nucleaire Geneeskunde en Moleculaire beeldvorming

External person

Hugo Oppelaar

  • Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis
  • Antoni Van Leeuwenhoek Hospital
  • Netherlands Cancer Institute
  • Utrecht University

External person

Ernst J. Postema

  • Department of Obstetrics and Gynaecology

External person

Wim J. G. Oyen

  • Radboud University Nijmegen
  • Institute of Cancer Research
  • European Organisation for Research and Treatment of Cancer Data Center
  • Radboud University Medical Center
  • Royal Marsden NHS Foundation Trust
  • Department of Obstetrics and Gynaecology

External person

Otto C. Boerman

  • Department of Obstetrics and Gynaecology

External person

Joey A. Muns

  • LinXis B.V.
  • LinXis BV

External person

Niels J. Sijbrandi

  • LinXis B.V.
  • LinXis BV

External person

Nicole L.W. Van Hal

  • VU Medisch Centrum

External person

Karl Heinz Heider

  • Boehringer Ingelheim GmbH

External person

Roeland Van Wijk

  • Utrecht University

External person

Samuel J. Bonacorsi

  • Bristol-Myers Squibb

External person

Qizhi Hu

  • Cristal Therapeutics

External person

Marian Salumbides

  • VU University Medical Hospital
  • Vrije Universiteit Amsterdam

External person

Berlinda J. de Wit-van der Veen

  • Netherlands Cancer Institute

External person

Ad H.G.J. Schrijvers

  • VU Medisch Centrum

External person

Ron H. J. Mathijssen

  • Erasmus Universiteit Rotterdam

External person

Ellen M.C. Knippels

  • VU Medisch Centrum

External person

Jonas T. Johnson

  • University of Pittsburgh
  • Department of Pittsburgh Cancer Institute

External person

L. Dubois

  • University of Amsterdam

External person

Jessica E. Wijngaarden

  • Vrije Universiteit Amsterdam
  • Amsterdam UMC

External person

W. Hayes

  • Bristol-Myers Squibb

External person

Johan R. de Jong

  • Afdeling Nucleaire Geneeskunde en Moleculaire beeldvorming
  • University of Groningen
  • University Medical Center Groningen

External person

Tapan K. Nayak

  • F. Hoffmann-La Roche AG

External person

P. Flamen

  • KU Leuven

External person

Jos J.P. Nauta

  • VU Medisch Centrum

External person

Albert Leyva

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam
  • Universidade Federal do Ceará

External person

Jose Saro

  • Roche Innovation Center Zurich
  • Roche Innovation Centre

External person

Vladimir Tolmachev

  • University Hospital
  • Uppsala University

External person

Marika Nestor

  • Uppsala University

External person

M. Schreurs

  • Vrije Universiteit Amsterdam

External person

Wasfi Al-Azzam

  • GSK, 19426 Collegeville, United States

External person

Myung Whun Sung

  • University of Pittsburgh
  • Department of Pittsburgh Cancer Institute

External person

Matti Anniko

  • Uppsala University

External person

W. Den Hollander

  • VU Medisch Centrum
  • Leiden University

External person

Joep W.G. Stroomer

  • VU Medisch Centrum

External person

D. Neri

  • Swiss Federal Institute of Technology

External person

Stefan Evers

  • Roche Innovation Center Zurich
  • Roche Innovation Centre

External person

Marijke Stigter Van Walsum

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Allan Jensen

  • Danish Cancer Society

External person

Corlinda B.M. Ten Brink

  • VU Medisch Centrum

External person

Willem Den Hollander

  • Department of Nuclear Medicine and Pharmacy
  • VU Medisch Centrum

External person

Eline J C Nieuwenhuis

  • VU University Medical Center
  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam
  • University Hospital

External person

R. Smith

  • Bristol-Myers Squibb

External person

Theresa L. Whiteside

  • University of Pittsburgh
  • W1041 Biomedical Science Tower

External person

Henri N. J. M. Greuter

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Jan Passchier

  • VU University Medical Centre
  • Erasmus Universiteit Rotterdam
  • University Medical Center Groningen
  • University of Groningen
  • Invicro

External person

Linda M. Velasquez

  • Bristol-Myers Squibb

External person

Kalevi J.A. Kairemo

  • University Hospital

External person

Ernesto Guarin

  • F. Hoffmann-La Roche AG

External person

T.K. Nayak

  • F. Hoffmann-La Roche AG

External person

Harry Hollema

  • University of Groningen
  • University Medical Center Groningen

External person

P. Morin

  • Bristol-Myers Squibb

External person

Thomas L. Mindt

  • Ludwig Boltzmann Institute
  • Swiss Federal Institute of Technology
  • Medical University of Vienna
  • University of Vienna

External person

Fred A.C. Wiegant

  • Utrecht University

External person

Corlinda Ten Brink

  • VU Medisch Centrum

External person

Wilbert A.M. Linnemans

  • Utrecht University

External person

Mats Bergstrom

  • GlaxoSmithKline

External person

Fiona A. Stewart

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital

External person

D. H. Brown

  • VU Medisch Centrum

External person

Alexandra Zanin

  • Tel Aviv University

External person

B. Bang-Andersen

  • H. Lundbeck A/S

External person

Günther R. Adolf

  • Boehringer Ingelheim GmbH

External person

Thomas E. Wuensche

  • Vrije Universiteit (VU) Amsterdam and VU Medical Center

External person

Kevin A. Adamzek

  • VU University Medical Center
  • Vrije Universiteit Amsterdam

External person

Hennie M.M. Schlüper

  • VU Medisch Centrum

External person

Andor W. J. M. Glaudemans

  • University of Groningen

External person

Rinat Eshel

  • Tel Aviv University

External person

Herman Gill

  • Genentech Incorporated

External person

S.G. Elias

  • Julius Health Care Centers

External person

A. Asuni

  • H. Lundbeck A/S

External person

Twan Lammers

  • Institute for Experimental Molecular Imaging, Aachen, Germany

External person

Henri A M Marres

  • Department of Obstetrics and Gynaecology
  • Radboud University Nijmegen

External person

Marc C. Huisman

  • Amsterdam UMC - Vrije Universiteit Amsterdam

External person

Sean Zhang

  • GSK, 19426 Collegeville, United States

External person

Shuyan Du

  • Bristol-Myers Squibb

External person

J Alain Kummer

  • VU Medisch Centrum
  • Utrecht University
  • Vrije Universiteit Amsterdam
  • St. Antonius Ziekenhuis
  • VU Medical Center
  • University of Lausanne

External person

Jan Marik

  • Genentech Incorporated

External person

I. Mes

  • Vrije Universiteit Amsterdam

External person

Bart Nijmeijer

  • Research and Development Department, Amsterdam, Netherlands

External person

Emilie M.J. van Brummelen

  • Netherlands Cancer Institute
  • Centre for Human Drug Research
  • Antoni Van Leeuwenhoek Hospital

External person

Cristianne Rijcken

  • Cristal Therapeutics

External person

Orit Sagi-Assif

  • Tel Aviv University

External person

Gilles Gasser

  • University of Zurich
  • École nationale supérieure de chimie de Paris

External person

Isaac P. Witz

  • Tel Aviv University

External person

David J. Donnelly

  • Bristol-Myers Squibb

External person

Bart Janssen

  • Heidelberg University

External person

M. Bagnay

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Els Kievit

  • VU Medisch Centrum

External person

Suzanne C van Es

  • University of Groningen

External person

Margreet S. Lang

  • Boehringer Ingelheim GmbH

External person

Ibrahim Aydin

  • Research and Development Department, Amsterdam, Netherlands
  • LinXis BV

External person

R. van Wijk

  • Erasmus MC
  • Utrecht University

External person

Marlies Sproll

  • Boehringer Ingelheim GmbH

External person

A. H.G.J. Schrijvers

  • VU Medisch Centrum

External person

Marie Louise Groot

  • VU University Medical Hospital
  • Vrije Universiteit Amsterdam

External person

Marcel P. M. Stokkel

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital
  • Utrecht University
  • Vrije Universiteit Amsterdam

External person

Dasa Lipovsek

  • Bristol-Myers Squibb

External person

Florian Heil

  • Roche Innovation Center Munich

External person

Yvonne W.S. Jauw

  • Vrije Universiteit Amsterdam

External person

Gerd Stehle

  • Boehringer Ingelheim GmbH

External person

Wouter B. Nagengast

  • University of Groningen
  • University Medical Center Groningen

External person

E. G. E. de Vries

  • University of Groningen

External person

Gerben J.C. Zwezerijnen

  • Vrije Universiteit Amsterdam

External person

Julliette E.M. Van Eerd

  • Department of Obstetrics and Gynaecology

External person

Linda J. de Wit-van der Veen

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital

External person

Marije Bolijn

  • VU University Medical Center
  • Vrije Universiteit Amsterdam

External person

Ruud J.R.W. Peters

  • ChemConnection BV/Ardena Oss

External person

Jean J.L. Tessier

  • F. Hoffmann-La Roche AG

External person

D. G. J. Linders

  • Leiden University

External person

Ilanah J. Pruis

  • Vrije Universiteit Amsterdam
  • Vrije Universiteit (VU) Amsterdam and VU Medical Center
  • Erasmus Universiteit Rotterdam

External person

Do-Youn Oh

  • Seoul National University

External person

J. H.M.S. Schellens

  • Netherlands Cancer Institute
  • Utrecht University
  • Antoni Van Leeuwenhoek Hospital
  • Slotervaart Hospital
  • Vrije Universiteit Amsterdam
  • Radboud University Nijmegen
  • Kirin Holdings Co., Ltd.
  • Netherlands C. Inst./A. van L. Hosp.
  • Erasmus Universiteit Rotterdam

External person

J. W K Gebbinck

  • VU University Medical Hospital

External person

Hans-Jurgen Wester

  • Technical University of Munich

External person

Denise E. Hilling

  • Leiden University

External person

Huib D. Mansvelder

  • Vrije Universiteit Amsterdam
  • King's College London
  • Vrije Universiteit (VU) Amsterdam and VU Medical Center

External person

Martine Stihle

  • F. Hoffmann-La Roche AG

External person

T. Ter Linden

  • VU University Medical Hospital

External person

David Maussang

  • VU University Medical Hospital
  • Vrije Universiteit Amsterdam
  • to-BBB technologies BV (now 2-BBB Medicines BV)

External person

Veena Vincent

  • GSK, 19426 Collegeville, United States

External person

Gerhard Wikström

  • Uppsala University

External person

Rolf Grempler

  • Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany
  • Boehringer Ingelheim GmbH

External person

Stuart P. McCluskey

  • Invicro LLC, London, UK

External person

Roel C. van der Schors

  • Vrije Universiteit Amsterdam

External person

H. Leverstein

  • Heliopolis Hospital

External person

Peter Brünker

  • Roche Innovation Center Zurich

External person

Frank W. Van Wagtendonk

  • VU Medisch Centrum

External person

M. van Herk

  • University of Manchester
  • Antoni Van Leeuwenhoek Hospital

External person

Philip H. Elsinga

  • University of Groningen, University Medical Center Groningen
  • University Medical Center Groningen
  • University of Groningen

External person

Wim E. Hennink

  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Netherlands
  • Utrecht University

External person

E. Boon

  • Radboud University Nijmegen

External person

M. Lubberink

  • VU University Medical Center

External person

Angè Le Kelder

  • VU Medisch Centrum

External person

Robert L. Janiczek

  • GlaxoSmithKline

External person

Joseph Cowell

  • École nationale supérieure de chimie de Paris

External person

C. J.F. Rijcken

  • Utrecht University
  • Cristal Therapeutics

External person

Ewoudt M. W. van de Garde

  • St. Antonius Ziekenhuis
  • Utrecht University

External person

Angel M. Carcaboso

  • Hospital Sant Joan de Déu

External person

Simon R. Cherry

  • University of California, Davis

External person

E.C. Dijkers

  • Academic Medical Center
  • University of Amsterdam
  • Amsterdam University Medical Centers
  • Electron Microscopy Center Amsterdam
  • Department of Pulmonary Medicine, Amphia Hospital, Breda, The Netherlands; Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

External person

Johan Wiegers

  • University of Groningen

External person

Jan M Fritz

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Alexander Staab

  • Boehringer Ingelheim GmbH

External person

Nicole Feller

  • VU Medisch Centrum

External person

A. L. Vahrmeijer

  • Department of Surgery, Leiden, Netherlands
  • Leiden University

External person

Gerald S.M.A. Kerner

  • University of Groningen

External person

Alfons J M Balm

  • VU Medisch Centrum
  • Netherlands Cancer Institute
  • University of Amsterdam
  • Antoni Van Leeuwenhoek Hospital
  • Vrije Universiteit Amsterdam

External person

M Persson

  • Uppsala University
  • University Hospital
  • Lund University

External person

Louise Cookson

  • GlaxoSmithKline

External person

S.C. van Es

  • University of Groningen

External person

Marian Bagnay

  • VU Medisch Centrum

External person

Kenneth Wester

  • University Hospital

External person

Oene Zwaagstra

  • Nuclear Research and Consultancy Group (NRG)

External person

Dick A.W. Laarman

  • VU Medisch Centrum

External person

M. P. Robson

  • University College London

External person

Dina Kapon

  • Tel Aviv University

External person

Miranda Siegmund

  • VU Medisch Centrum

External person

Rogier Mous

  • Utrecht University
  • Sanquin Blood Supply Foundation

External person

Christian Klein

  • Roche Innovation Center Zurich

External person

Eric Berg

  • University of California, Davis

External person

Karen Zwanenpoel

  • Transplant Surgery

External person

Gunnar Antoni

  • Uppsala University

External person

Marian A B D Plaizier

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Scott D. Solomon

  • Harvard University

External person

Margot E.T. Tesselaar

  • Antoni Van Leeuwenhoek Hospital
  • Netherlands Cancer Institute

External person

Javier Garcia-Corbacho

  • Hospital Clinic de Barcelona
  • University of Barcelona

External person

Ignacio Melero

  • University of Navarra

External person

A. Huhalov

  • University College London

External person

F. Cailler

  • SurgiMAb

External person

Philippe Aftimos

  • Université libre de Bruxelles

External person

Pieter L. Jager

  • Afdeling Nucleaire Geneeskunde en Moleculaire beeldvorming
  • University of Groningen
  • Harvard University
  • Broad Institute

External person

I. L. Schadee-Eestermans

  • VU Medisch Centrum

External person

Mabrouk Elgadi

  • Boehringer Ingelheim Pharmaceuticals

External person

A. Rapoport

  • Heliopolis Hospital

External person

Esther Kooijman

  • VU University

External person

Wouter V. Vogel

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital

External person

A. Fischer

  • Max Planck Institute for Nuclear Physics

External person

Sebastian Neumann

  • F. Hoffmann-La Roche AG

External person

Simone Pieplenbosch

  • Department of Hematology, 1081 HV Amsterdam, Netherlands
  • Department of Radiology & Nuclear Medicine, Amsterdam, Netherlands
  • Vrije Universiteit Amsterdam

External person

Nechama I. Smorodinsky

  • Tel Aviv University

External person

C. Roth

  • Vrije Universiteit Amsterdam

External person

R. B. Pedley

  • University College London

External person

Hendrik-Tobias Arkenau

  • Sarah Cannon Research Institute SCRI UK

External person

Hein Leverstein

  • VU Medisch Centrum

External person

Armin Sepp

  • GlaxoSmithKline

External person

Ahmad Awada

  • Université libre de Bruxelles

External person

Patrick Pauwels

  • University of Antwerp

External person

Ronen Alon

  • Weizmann Institute of Science

External person

Alphons H. H. Bongaerts

  • University of Groningen

External person

David M. Goldenberg

  • Center for Molecular Medicine and Immunology

External person

M. Feilke

  • Roche Innovation Centre

External person

Marcel P. Copper

  • VU Medisch Centrum
  • Dept. Otolaryngol. Hd. Neck Surg.
  • Vrije Universiteit Amsterdam

External person

Carolina P Schröder

  • University of Groningen

External person

Mark Lubberink

  • VU Medisch Centrum
  • Antoni Van Leeuwenhoek Hospital
  • Department of Pharmacy
  • Department of Obstetrics and Gynaecology, Onze Lieve Vrouwe Gasthuis

External person

Marthin O. Kwakkelstein

  • Boehringer Ingelheim GmbH

External person

Erwin J. G. Peterman

  • Vrije Universiteit Amsterdam

External person

Nanno H. Mulder

  • University of Groningen

External person

Alejandro Perez Pitarch

  • Boehringer Ingelheim Pharma GmbH & Co. KG Biberach

External person

Giuseppe Giaccone

  • VU Medisch Centrum
  • Slotervaart Hospital
  • Netherlands Cancer Institute
  • Vrije Universiteit Amsterdam
  • Radboud University Nijmegen
  • Kirin Holdings Co., Ltd.
  • Utrecht University

External person

R. ATTEWELL

  • Lund University

External person

Sjerp M. Weima

  • Utrecht University

External person

Ashutosh Wechalekar

  • Great Ormond St Hospital for Children NHS Trust

External person

J. Bart

  • University Medical Center Groningen

External person

Valeria G. Nicolini

  • Roche Innovation Center Zurich

External person

Dennis Schamhart

  • Utrecht University

External person

Aniek J G Even

  • Maastricht University

External person

David Wittig

  • Roche Innovation Center Zurich

External person

Jos G.W. Kosterink

  • University of Groningen

External person

Mikael Persson

  • Uppsala University

External person

Ann Hoeben

  • Maastricht University Medical Center
  • Maastricht University

External person

Hugh D. Davis

  • Centocor, Inc.

External person

Mary Birchler

  • GSK, 19426 Collegeville, United States

External person

Gerrit-Jan Liefers

  • Department of Surgery, Leiden, Netherlands

External person

D. Leung

  • Bristol-Myers Squibb

External person

Mariska Verlaan

  • VU University
  • Amsterdam UMC

External person

Gerd Munzert

  • Boehringer Ingelheim GmbH

External person

Jim N. Herron

  • University of Utah

External person

Pablo Umaña

  • Roche Innovation Center Zurich

External person

Carla M L van Herpen

  • Radboud University Medical Center
  • Radboud University Nijmegen

External person

Mathijs H. Van Schie

  • Boehringer Ingelheim GmbH

External person

O. van Tellingen

  • Netherlands Cancer Institute

External person

Torsten Dreier

  • Argenx
  • AgomAb Therapeutics NV, 9000, Ghent, Belgium

External person

David R. Bonsall

  • Invicro LLC, London, UK

External person

Wolfgang A. Weber

  • University of Oxford
  • Rutherford Appleton Laboratory

External person

Ivan Penuelas

  • University of Navarra

External person

A. Jensen

  • H. Lundbeck A/S

External person

Harry J. M. Groen

  • University of Groningen, University Medical Center Groningen
  • University Medical Center Groningen
  • University of Groningen
  • UMCG/RU Groningen

External person

Sang We Kim

  • University of Ulsan

External person

Inja Waldhauer

  • Roche Innovation Center Zurich

External person

John Dring

  • University Hospital

External person

Louis Van De Zande

  • Utrecht University

External person

Afsar Rahbar

  • Karolinska Institutet
  • Department of Medicine Solna

External person

James E. Looney

  • Centocor, Inc.

External person

Reiner Meyer

  • Boehringer Ingelheim GmbH

External person

Marion M. Deken

  • Leiden University

External person

Bernard Meunier

  • Laboratoire de chimie de coordination

External person

Lioe-Fee de Geus-Oei

  • Leiden University
  • University of Twente

External person

Samuel Moser

  • Roche Innovation Center Zurich

External person

Maria Cristina de Vera Mudry

  • F. Hoffmann-La Roche AG

External person

Dhaval K. Shah

  • SUNY Buffalo

External person

Olga Hamming-Vrieze

  • Netherlands Cancer Institute

External person

Chris Klaver

  • Vrije Universiteit Amsterdam

External person

Eli C.F. Dijkers

  • University of Groningen
  • Afdeling Nucleaire Geneeskunde en Moleculaire beeldvorming
  • University Medical Center Groningen

External person

Wilhelmina C A M Buijs

  • Department of Obstetrics and Gynaecology

External person

Thijs H.Oude Munnink

  • University of Groningen

External person

Satoshi Yasumura

  • University of Pittsburgh
  • Department of Pittsburgh Cancer Institute

External person

Amina Ahbari

  • Department of Radiology and Nuclear Medicine

External person

Sabine Lang

  • Roche Innovation Center Zurich

External person

K. P. Dingemans

  • Academic Medical Centre, University of Amsterdam

External person

Cristina Mari

  • University of Zurich

External person

Mary Ann Lukas

  • GlaxoSmithKline

External person

Zoja Streumer-Svobodova

  • Utrecht University

External person

E. M C Rood-Knippels

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Marijke Stigter Van Walsum

  • VU University Medical Centre

External person

F.C.S. Ramaekers

  • Department of Obstetrics and Gynaecology

External person

Thomas Hofer

  • Roche Innovation Center Zurich

External person

Simon G. Williams

  • Genentech Incorporated

External person

Kevin Adamzek

  • Department of Radiology and Nuclear Medicine
  • VU University Medical Centre

External person

Jasper J. Ouak

  • VU Medisch Centrum

External person

M. A.J.A. Hermsen

  • VU Medisch Centrum
  • VU University Medical Hospital
  • University of Oviedo
  • Vrije Universiteit Amsterdam
  • University Hospital

External person

Rob C. Roovers

  • Utrecht University
  • VU Medisch Centrum

External person

Wifred F. den Dunnen

  • University of Groningen

External person

E.U. Emir

  • University College London

External person

Janny Dijkstra

  • VU University Medical Center
  • Vrije Universiteit Amsterdam

External person

A. ASK

  • Departments of Oncology

External person

M. Paesmans

  • Université libre de Bruxelles

External person

H. J. Jensen

  • Righshospitalet

External person

A. Schrijvers

  • Heliopolis Hospital

External person

James Storey

  • GlaxoSmithKline

External person

Jan H M Schellens

  • Netherlands Cancer Institute
  • Utrecht University
  • Slotervaart Hospital

External person

Ingo H. Gorr

  • F. Hoffmann-La Roche AG

External person

Marianne Budde

  • VU Medisch Centrum

External person

Wouter van Elmpt

  • Maastricht University

External person

J. G.P. Brakkee

  • VU Medisch Centrum

External person

Rodney H. Falk

  • Brigham and Women's Hospital

External person

S. Christensen

  • H. Lundbeck A/S

External person

Lisa A. Wells

  • Invicro LLC, London, UK

External person

Franck Morschhauser

  • Centre Hospitalier Universitaire

External person

Elínborg Ostermann

  • Boehringer Ingelheim GmbH

External person

Christian Gerdes

  • Roche Innovation Center Zurich

External person

R. Brakenhof

  • VU Medisch Centrum

External person

Paolo Michieli

  • AgomAb Therapeutics NV, 9000, Ghent, Belgium
  • University of Turin

External person

H. Lundqvist

  • University Hospital

External person

Cornelis van de Velde

  • Leiden University

External person